Page 2385 - Cote clinical veterinary advisor dogs and cats 4th
P. 2385

Urethral Stent Placement   1179


                                                ○   The port is flushed with sterile saline to   •  Urethropexy, cystourethropexy: may have a
                                                  remove all air trapped in the diaphragm,   70% success rate combined with culposus-
  VetBooks.ir            AUS Occluder Catheter   ○   Saline is then gradually introduced 0.1 mL   •  Transobturator vaginal tape: invasive, 33%
                                                                                    pension, 21% complication rate
                                                  and then all saline is removed.
                                                                                    postoperative  dysuria  rate,  delayed  fistula
                                                  at  a  time  to  determine  the  degree  of
                                                                                    formation
                                                  occlusion  achieved  with  each  0.1-mL
                         connected to the port
                                                  infusion.                       •  Transpelvic  urethral  sling:  invasive,  less
                    CompanionPort - a Vascular Access Port,   ○   Maximum fluid volume is noted in the   than 50% long-term continence rate, fistula
                    connects to the AUS occluder catheter by  medical record.       formation
                    means of a blue boot
                                               •  The AUS should remain completely deflated
                                                for 6 weeks after surgery to allow for resolu-  Pearls
                                                tion of inflammation and revascularization   •  Err  on  the  side  of  oversizing  rather  than
                                                of periurethral tissue.             undersizing  the  AUS  to  avoid  urethral
                                                                                    obstruction.
                                               Postprocedure                      •  Huber point needles must be used through
           URETHRAL OCCLUDER PLACEMENT  Artificial                                                                    Procedures and
           urethral sphincter (i.e., urethral occluder) device for   •  The  patient  remains  in  the  hospital  until   the vascular access port.  Techniques
           implantation. The metallic port is used to attach a   urination without straining is observed.
           Huber point needle for addition or removal of fluid   •  Recheck  examination  at  6  weeks  post-  SUGGESTED READING
           in the occluder portion, which is surgically placed   operatively  to  begin  inflating  the  cuff  in   Currao RL, et al: Use of a percutaneously controlled
           around  the  urethra.  (Copyright  2011, Norfolk  Vet   0.05-0.2 mL increments.  urethral hydraulic occluder for treatment of refrac-
           Products, Skokie, IL.)                                                  tory urinary incontinence in 18 female dogs. Vet
                                               Alternatives and Their              Surg 42:4, 2012.
                                               Relative Merits
           •  The  2-0  polypropylene  suture  is  threaded   •  Submucosal urethral injections of bulking   AUTHOR: Jill K. Luther, DVM, MS, DACVS
                                                                                  EDITORS: Leah A. Cohn, DVM, PhD, DACVIM; Mark S.
             through the eyelets of the AUS and tied to   agents: less invasive, temporary effects  Thompson, DVM, DABVP
             close the cuff.                   •  Culposuspension: no implants needed, up
           •  Calibration of the occluder       to 55% reported success rate






            Urethral Stent Placement                                                               Client Education
                                                                                                          Sheet


           Difficulty level: ♦♦♦                imaging, allowing faster and more precise   Possible Complications and
                                                stent placement.                  Common Errors to Avoid
           Overview and Goal                   •  Software package for making measurements   Patients should be referred to a formally trained
           Placement of a permanent, expandable stent   from fluoroscopic images or calculator for   and experienced specialist.
           to relieve urethral obstruction and re-establish   manual measurements  •  An inappropriately small stent increases the
           urine stream in a patient with partial or com-  •  Appropriately sized, self-expanding, metallic   risk of stent migration.
           plete obstruction                    urethral stent (Vet-Stent-Urethra by Infiniti   •  Misplaced  stent  or  one  not  spanning  the
                                                Medical, Menlo Park, CA). An inventory of   entire obstruction can result in persistent
           Indications                          various lengths and diameters of stents allows   urethral obstruction.
           Urethral  obstruction  (p.  1009)  refractory  to   diagnosis and placement to occur under the   •  After stent placement, care must be taken
           standard of care:                    same anesthesia.                    when performing a rectal palpation or taking
           •  Urethral/bladder trigonal neoplasia (p. 991)  •  A  removable,  silicone-covered  nitinol  stent   a rectal temperature because the stent could
           •  Benign urethral stricture         (Allium  Medical  Caesarea  Industrial  Park   become damaged or compressed.
           •  Prostatic neoplasia (p. 828) causing urethral   South, Caesarea, Israel) has been used in a
             obstruction                        few veterinary patients with promising results.  Procedure
           •  Sustained  urethral  spasm  refractory  to   •  Iodinated  contrast  medium,  introducer   •  Under general anesthesia, place animal in
             medical therapy                    sheath  (generally  8 Fr),  marker  catheter,   lateral recumbency.
                                                0.035-inch hydrophilic guide wire (HGW),   •  The prepuce or vulvar region is aseptically
           Contraindications                    Berenstein catheter                 prepared.
           •  Self-expanding  nitinol  urethral  stents  are                      •  A  marker  catheter  is  advanced  into  the
             permanent; they are not amenable to removal.  Anticipated Time         terminal  portion  of  the  colon  over  a
           •  If the obstruction can be relieved through   60-90 minutes            0.035-inch-diameter  HGW.  This  marker
             another means without requiring a perma-                               catheter allows correction of magnification
             nent implant, it should be done. A removable   Preparation: Important   and is essential in selection of stent size. The
             urethral stent can be considered in this   Checkpoints                 marker catheter can be placed in a 14-Fr red
             situation.                        •  Ensure  multiple-sized  urethral  stents  are   rubber catheter to protect it from kinking.
                                                available.                        •  Proper catheter and patient positioning is
           Equipment, Anesthesia               •  Ensure  the  owner  understands  urinary   verified by fluoroscopy.
           •  General anesthesia is required.   incontinence  can  occur  (25%  in  females/  •  A  0.035-inch  HGW  is  inserted  into  the
           •  Fluoroscopy or digital radiology. Fluoroscopy   males after placement of a urethral stent for   urethra and advanced into the bladder under
             is  preferred  because  it  provides  real-time   obstructive neoplasia).  fluoroscopic guidance.

                                                      www.ExpertConsult.com
   2380   2381   2382   2383   2384   2385   2386   2387   2388   2389   2390